Dogwood Therapeutics, Inc.
Calidad de datos: 83%
DWTX
Nasdaq
Manufacturing
Chemicals
$2.00
▲
$0.06
(3.09%)
Cap. Mercado: 66.59 M
Precio
$2.00
Cap. Mercado
66.59 M
Rango del Día
$1.97 — $2.11
Rango de 52 Semanas
$1.77 — $9.50
Volumen
37,586
Apertura $2.06
Promedio 50D / 200D
$2.82
29.07% below
Promedio 50D / 200D
$4.60
56.49% below
Quick Summary
Puntos Clave
Negative free cash flow of -15.62 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-484.66%
Below sector avg (-51.02%)
ROIC-23.99%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio4.49
Interest CoverageN/A
Valoración
PE (TTM)
-1.94
Above sector avg (-1.98)
P/B Ratio9.17
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.9 | -2.0 |
| P/B | 9.2 | 5.1 |
| ROE % | -484.7 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -34.26 M |
| ROE | -484.66% | ROA | -36.31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -15.62 M |
| ROIC | -23.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.49 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 9.06 M | Tangible Book Value | -72.87 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.94 | Forward P/E | N/A |
| P/B Ratio | 9.17 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -23.45% | ||
| Market Cap | 66.59 M | Enterprise Value | 56.46 M |
| Per Share | |||
| EPS (Diluted TTM) | -7.13 | Revenue / Share | N/A |
| FCF / Share | -0.47 | OCF / Share | -0.47 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 45.59% |
| SBC-Adj. FCF | -15.96 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -34.26 M | -12.35 M | -5.30 M | -12.25 M | -15.96 M |
| EPS (Diluted) | -7.13 | -12.52 | -0.28 | -1.11 | -1.92 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -27.97 M | -12.23 M | -5.45 M | -12.32 M | -15.64 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 21.87 M | 3.53 M | 1.73 M | 8.07 M | 10.80 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | 150,904.0 | 67,475.0 | 5,672.0 |
| Income Tax | 221,096.0 | -503.0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.17 M | 94.31 M | 4.17 M | 8.37 M | 15.78 M |
| Total Liabilities | 15.27 M | 30.03 M | 358,548.0 | 1.04 M | 1.28 M |
| Shareholders' Equity | 74.90 M | -10.12 M | 3.81 M | 7.33 M | 14.50 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 6.52 M | 14.85 M | 3.32 M | 7.03 M | 14.01 M |
| Current Assets | 8.43 M | 16.54 M | 4.17 M | 8.37 M | 15.78 M |
| Current Liabilities | 3.06 M | 3.18 M | 358,548.0 | 1.04 M | 1.28 M |
{"event":"ticker_viewed","properties":{"ticker":"DWTX","listing_kind":"stock","pathname":"/stocks/dwtx","exchange":"Nasdaq","country":"US"}}